West Virginia University Logo

December 25, 2013


SAMHSA Prescription Drug Abuse Weekly Update
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports News Other State and Local News Other Resources Videos Grant Announcement Take-Back Events and Drop Boxes Upcoming Conferences and Workshops

Featured Article

R.J. Hamill–Ruth, K. Larriviere, and M.G. McMasters. 2013. "Addition of Objective Data to Identify Risk for Medication Misuse and Abuse: The Inconsistency Score." Pain Medicine 14(12):1900–07. doi:10.1111/pme.12221.

First-time patients at a multidisciplinary pain management center completed a brief questionnaire about recent prescription, over-the-counter, and illicit drug use before providing a urine sample. Two hundred and nine patients were polled and 118 specimens were collected. Discrepancies between patient report, the Virginia prescription monitoring program (PMP), referring physician records, and point-of-care urine drug screen results were analyzed. The mean age of participants was 48.2 years (22–83); 65.3 percent were female. Of those using opioids, 28 percent (10/36) did not self-report use. Of those using benzodiazepines, 41 percent (16/39) did not self-report use. The PMP recorded no prescriptions for 44 percent (17/39) of benzodiazepine users. Inconsistencies were scored from 0 (none) to a maximum of 2 points (2+ discrepancies) for each potential comparator. The maximum potential inconsistency score (IS) was 16 points. IS scores ranged from 1 to 11; 52.5 percent of patients had an IS ≥ 3. Higher IS scores correlated with higher numbers of pharmacies, prescribing physicians, prescriptions on the PMP, and presence of illicit substances in urine. Addition of urine drug screen or PMP to patient report and physician records increased identification of inconsistencies by > 400 percent and PMP plus urine drug screen by > 900 percent. Patient report and the medical record are inadequate for screening of aberrant drug-related behaviors. Addition of PMP and urine drug screen contribute significantly to identification of inconsistencies through higher IS scores and differentiate patients at higher risk for medication misuse, abuse, or diversion. Editor's note: This study has implications for evaluation design and misuse screening programs. It also suggests the self-report estimates of prescription drug misuse that form the backbone of current epidemiology may underestimate by roughly 40 percent.

Read more:

Journal Articles and Reports

E.E. Bonar, M.A. Ilgen, M. Walton, and A.S.B. Bohnert. 2014. "Associations Among Pain, Non-Medical Prescription Opioid Use, and Drug Overdose History." The American Journal on Addictions 23(1):41–47. doi:10.1111/j.1521-0391.2013.12055.x.

Researchers observed associations between pain, nonmedical prescription opioid (NMPO) use, and overdose in substance use disorder (SUD) treatment patients. Among 342 patients at a residential SUD treatment center, logistic regression examined association of overdose with pain, adjusting for substance use, suicide attempts, and demographics. Pain was positively related to NMPO use. Heroin use, suicide attempts, pain, and NMPO use were positively associated with overdose. Accounting for NMPO use weakened the pain–overdose relationship.

Read more:

J.G. Bramness, B. Henriksen, O. Person, and K. Mann. 2014. "A Bibliometric Analysis of European Versus USA Research in the Field of Addiction. Research on Alcohol, Narcotics, Prescription Drug Abuse, Tobacco and Steroids 2001–2011." European Addiction Research 20(1):16–22. doi:10.1159/000348260.

This bibliometric study uses Thomson Reuters Web of Knowledge as its data source. Forty key words were used as search terms, but certain scientific publications not concerning the issue were excluded. Scientific publications from Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the United States were studied. In addition to the citation indices, the number of publications in each country and year was retrieved. Approximately two thirds of publications came from the United States. Europe lagged behind, both in absolute and relative figures. The trend over the past decade was a bigger gap between the amount of research performed in Europe versus the United States. Smaller European countries had a greater relative publication rate and citations were relatively evenly distributed. It has been claimed that 85 percent of the world's research on drug abuse and dependence is carried out in the United States.

Read more:

D.W. Light, J. Lexchin, and J.J. Darrow. 2013. "Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs." The Journal of Law, Medicine & Ethics 41(3):590–600. doi:10.1111/jlme.12068.

Over the past 35 years, patients have suffered from a largely hidden epidemic of side effects from drugs that usually have few offsetting benefits. According to this paper, the pharmaceutical industry has corrupted medical practice through its influence over what drugs are developed, how they are tested, and how medical knowledge is created. Since 1906, heavy commercial influence has compromised congressional legislation to protect the public from unsafe drugs. The authorization of user fees in 1992 turned drug companies into the Food and Drug Administration's (FDA's) prime clients, deepening the regulatory and cultural capture of the agency. Industry has demanded shorter average review times, but with less time to thoroughly review evidence, increased hospitalizations and deaths have resulted. Meeting the needs of drug companies has taken priority over meeting patients' needs. Unless this corruption of regulatory intent is reversed, the situation will continue to deteriorate. Researchers offer practical suggestions, including separating funding of clinical trials from their conduct, analysis, and publication; independent FDA leadership; full public funding of all FDA activities; measures to discourage research and development on drugs with few, if any, new clinical benefits; and creation of a National Drug Safety Board.

Read more:

C.S. Meade, L.A. Bevilacqua, E.D. Moore, M.L. Griffin, J.G. Gardin, J.S. Potter, M. Hatch–Maillette, and R.D. Weiss. 2014. "Concurrent Substance Abuse Is Associated with Sexual Risk Behavior Among Adults Seeking Treatment for Prescription Opioid Dependence." The American Journal on Addictions 23:27–33. doi:10.1111/j.1521-0391.2013.12057.x

Despite the rising prevalence of prescription opioid dependence in the United States, little is known about sexually transmitted HIV risk in this population. This study examined prevalence of sexual risk behavior among opioid-dependent patients who use prescription opioids primarily for nonmedical purposes. As part of a multisite clinical trial, participants (N = 653) completed a baseline assessment that included the Risk Behavior Survey. In the past month, 74 percent had been sexually active. Of these, most had opposite-sex partners (97.3 percent) and vaginal intercourse (97.1 percent); anal intercourse was uncommon (3.1 percent). The majority reported unprotected intercourse (76.5 percent), but few had multiple partners (11.3 percent). Unprotected intercourse was associated with history of other substance dependence (adjusted odds ratio [AOR] = 1.73); having multiple partners was associated with concurrent cocaine use (AOR = 2.54). Injection drug use in the past month was rare (2.5 percent). While the majority of sexually active participants engaged in unprotected intercourse, the proportion with multiple sex partners was low relative to other samples that use illicit drugs. Among people with nonmedical prescription opioid dependence, those who concurrently use other substances may have a higher risk for HIV infection.

Read more:

T.S. Peixe, R.M. de Almeida, E. Girotto, S.M. de Andrade, and A.E. Mesas. 2013. "Use of Illicit Drugs by Truck Drivers Arriving at Paranaguá Port Terminal, Brazil." Traffic Injury Prevention. doi:10.1080/15389588.2013.868893

This cross-sectional study was part of a larger research project conducted among drivers transporting grain to a regional Brazilian port. Data on professional characteristics, involvement in road traffic injuries, sleep, and use of alcohol and illicit drugs were collected with a questionnaire. Urine samples were also collected from 62 drivers and analyzed for amphetamines, cocaine, and cannabis using gas chromatography with mass spectrometric detection. Toxicological analyses showed 8.1 percent (95 percent confidence interval [CI] 2.7–17.8 percent) of the urine samples were positive for drugs (4.8 percent for cocaine, 1.6 percent for amphetamine, and 1.6 percent for both). No sample was positive for cannabinoids. Drug use during the preceding 30 days was reported by 8.1 percent; only one tested positive for the drug in the urine sample. At least 14.5 percent (95 percent CI 6.9–25.8 percent) had used illicit drugs during the preceding 30 days based on self-reports and urine testing. Drivers who reported involvement in traffic injuries the year before more often tested positive for drugs in biological samples (p < 0.05).

Read more:

H.G. Pope, R. Wood, A. Rogol, F. Nyberg, L. Bowers, and S. Bhasin. 2013. "Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement." Endocrine Reviews. doi:10.1210/er.2013-1058.

This scientific statement synthesizes available information on medical consequences of performance-enhancing drug (PED) use, identifies gaps in knowledge, and aims to focus the medical community and policymakers' attention on PED use as an important public health problem. PED users frequently consume highly supraphysiologic doses, combine them with other PEDs and/or other classical drugs of abuse, and display additional associated risk factors. PED use has been linked to increased risk of death and a wide variety of cardiovascular, psychiatric, metabolic, endocrine, neurologic, infectious, hepatic, renal, and musculoskeletal disorders. As randomized trials cannot ethically duplicate the large doses of PEDs and many factors associated with use, researchers need observational studies to collect valid outcome data on associated health risks. In addition, studies are needed on prevalence of PED use, the mechanisms by which PEDs exert adverse health effects, and the interactive effects of PEDs with sports injuries and other high-risk behaviors. Also needed are randomized trials to assess therapeutic interventions for treating PED adverse effects, such as anabolic-androgen steroid withdrawal syndrome.

Read more:

R.C.B. Manworren. 2013. "Mandatory Continuing Education for Opioid Prescribers." Pain Medicine 14(12):1822–24. doi:10.1111/pme.12285_3.

This article discusses three trends that support the need for mandatory continuing education (CE) among opioid prescribers: 1) The amount of time devoted to educating healthcare professionals to assess and treat pain is disproportionately low compared with the prevalence of pain across the lifespan, 2) Accreditation of CE programs and their associated conflict-of-interest disclosure policies help learners differentiate evidence-based educational material from product promotion and marketing, and 3) The increased prevalence of opioid use, diversion, addiction, and opioid-related deaths necessitates dissemination of new knowledge to prescribers.

Read more:

M.E. Schatman and B.D. Damall. 2013. "Pain CME: Misguided Direction?" Pain Medicine 14(12):1824–25.

The authors discuss the importance of mandatory education to improve proper physician treatment of chronic pain. They emphasize the ethical and practical demand for continuing education with an end goal to improve patient outcomes and cite the need for creative ways to support and incentivize primary care physicians who show competence in pain treatment and pain care practices.

Read more:

M. Soyka and T. Hillemacher. 2014. "Commentary on Hser et al. (2014): To Retain or Not to Retain—Open Questions in Opioid Maintenance Therapy." Addiction 109(1):88–89. doi:10.1111/add.12376.

This paper weighs the importance of opioid maintenance therapy, which entails replacing an illegal opioid drug with other drugs under medical supervision. The authors discuss the result of the study on diamorphine and oral morphine use as maintenance treatment for special subgroups of opioid-dependent patients and highlight the role of the induction phase in opioid maintenance therapy.

Read more:

House of Commons London: The Stationery Office Limited. 2013. "Drugs: New Psychoactive Substances and Prescription Drugs, Twelfth Report of Session 2013–14."

The Commons Home Affairs Committee said general practitioners should start anonymously tracking patients addicted to prescription drugs. Their report highlights continued market growth for "legal highs" or new psychoactive substances and indicates that figures showing legal highs were mentioned as a factor in 52 deaths in 2012 (compared with 29 in 2011). The committee has demanded government action and wants to see on-site testing labs established by police at festivals throughout Britain to facilitate removal of harmful or illegal substances.

Read more:

W. Wolff and R. Brand. 2013. "Subjective Stressors in School and Their Relation to Neuroenhancement: A Behavioral Perspective on Students' Everyday Life 'Doping.'" Substance Abuse Treatment, Prevention, and Policy 8:23. doi:10.1186/1747-597X-8-23.

Researchers empirically tested if different neuroenhancement (NE) variants (lifestyle drug, prescription drug misuse, and illicit substance use) could be linked to school stressors. Participants included 519 students (25.8 ± 8.4 years old, 73.1 percent female). Logistic regressions indicate a modified doping attitude scale can predict all three variants. Multiple NE substance abuse was frequent, and overwhelming school demands were associated with lifestyle and prescription drug NE. Researchers should be sensitive to probable structural similarities between enhancement in everyday life and sport, and systematically explore where findings from one domain can be adapted for the other.

Read more:


Prescription Drug Deaths Prompt Call for Review of Free Medicine
BBC News
December 20, 2013

Cais, a local Welsh charity, said free prescriptions in Wales should be reviewed because of concerns about deaths involving prescription drugs. A report from the Home Affairs Select Committee highlighted figures released earlier this year by the Office for National Statistics, indicating deaths involving the opiate tramadol had risen to 175 in 2012 in England and Wales, compared with 83 in 2008. The co-chair of the British Medical Association's General Practitioner Committee for Wales dismissed the notion that free prescriptions were contributing to the problem. A Welsh government spokesperson said the Substance Misuse Delivery Plan outlined actions under way to curb misuse.

Read more:

Bill Would Tally Ohio's Addicted Newborns
The Columbus Dispatch
December 18, 2013

Ohio legislators might require hospitals to report the number of newborns addicted to drugs next year. In January, the House Health and Aging Committee will vote on House Bill 315, which would require hospitals to report the number of opioid-dependent newborns. The Ohio Department of Health will write the reporting rules and information could not be passed to law enforcement agencies.

Read more:

Adderall Abuse Increases Among High School Students
Digital Journal
December 18, 2013

The University of Michigan's 2013 Monitoring the Future Study, a survey of approximately 41,600 youth in 8th, 10th, and 12th grades, revealed an increase in Adderall abuse among high school seniors over the past few years. The rise has been steady since 2009, when the abuse rate was 5.4 percent. In 2010 and 2011, past-year Adderall abuse increased to 6.5 percent among 12th graders, continued increasing to 7.6 percent in 2012, and now stands at 7.4 percent. Only 2.3 percent of high school seniors reported Ritalin abuse. Vicodin abuse decreased over the past 10 years, now 5.3 percent for high school seniors compared with 10.5 percent in 2003. Only 5 percent of seniors reported abusing cough products containing dextromethorphan, down from 6.9 percent in 2006.

Read more:

China Arrests 1,300 People for Selling Fake Drugs
The Fix
December 18, 2013

Chinese police arrested 1,300 suspects for producing and selling fake prescription medication online. Roughly 140 illegal Web sites and online pharmacies in 29 provinces and cities throughout China have been shut down since last June, with 2.2 billion Yuan's worth ($362.4 million) of fake drugs and raw materials seized. Last year, the number of prosecutions totaled 8,000—a fivefold increase from the year before.

Read more:

Care and Compassion Needed for Addicted Mothers-To-Be
December 15, 2013

Blake Bradley, an obstetrician and gynecologist, says healthcare professionals should be nonjudgmental when addressing the care of drug-addicted mothers and babies. He suggests screening for opiate abuse as part of all routine prenatal care, conducted in a consistent and confidential way.

Read more:

Better Pain Management Is Essential for Reducing Addiction to Prescription Painkillers
The Huffington Post
December 16, 2013

Michael Friedman, adjunct associate professor at Columbia University, shares his views about the need for doctors to better help patients eliminate, reduce, or tolerate pain. When Friedman reviewed comments from previous articles he'd written, he discovered some people knew they were addicted but believed they needed pain relievers to have a life. Friedman has also suffered from pain. It took 2 years, 15 medical professionals, and an MRI to reveal a large tumor inside his spinal column. He says physicians need to be far more cautious about prescribing pain relievers, but that doctors and patients should consider alternatives, including exercise, weight loss, and over-the-counter pain relievers before opiates. Friedman would like to see prescription drug abuse campaigns include efforts to help physicians and patients more effectively address pain.

Read more:

ACP Issues Wake-Up Call on Prescription Drug Abuse
December 19, 2013

Medscape Medical News interviewed American College of Physicians (ACP) President Molly Cooke about ACP's policy position paper on prescription drug abuse (see "Prescription Drug Abuse: A Policy Position Paper from the American College of Physicians" in the December 18, 2013, Weekly Update). ACP issued the paper because of deaths and adverse consequences linked to abuse of certain prescription drugs. Cooke said increasing opioid use has been encouraged by various recommendations promoting aggressive treatment of pain symptoms. She hopes the paper will encourage doctors to broaden their conversations with patients when prescribing drugs that could be subject to abuse or misuse and recognize some patients need more structure when using such medications.

Read more:

The Selling of Attention Deficit Disorder
The New York Times
December 14, 2013

This article discusses the increase in the number of attention deficit hyperactivity disorder (ADHD) diagnoses and stimulant prescriptions during a 20-year drug marketing campaign. Pharmaceutical companies publicized the disorder and promoted pills to doctors, educators, and parents. Stimulant medication profits increased from $1.7 million a decade ago to nearly $9 million in 2012, according to IMS Health. Since 2000, the Food and Drug Administration has cited every major ADHD drug for false and misleading advertising—some multiple times. Now, pharmaceutical companies are using similar marketing techniques to focus on adults with ADHD.

Read more:

Two-Thirds of U.S. Residents Who First Started Using Drugs in the Past Year Began with Marijuana; 26% Started with Nonmedical Use of Prescription Drugs, Primarily Pain Relievers
CESAR FAX, Center for Substance Abuse Research
December 16, 2013

According to the 2012 National Survey on Drug Use and Health, an estimated 2.9 million people age 12 or older used an illicit drug other than alcohol or nonmedically used a prescription drug for the first time in the past year. Two thirds (66 percent) of new users reported marijuana was the first drug they tried. Slightly more than one fourth (26 percent) reported that nonmedically used prescription drugs, including pain relievers (17 percent), tranquilizers (4 percent), stimulants (4 percent), and sedatives (1 percent), were the first they tried. Less than 10 percent reported that their first use of drugs involved inhalants or hallucinogens, and very few people started using with cocaine or heroin.

Read more:

U.S. Congressmen Matt Cartwright and Blake Farenthold Introduce Bipartisan Servicemembers and Veterans Prescription Drug Safety Act of 2013
United States Representative Matt Cartwright
December 16, 2013

U.S. Congressmen Matt Cartwright and Blake Farenthold introduced H.R. 3714, the Servicemembers and Veterans Prescription Drug Safety Act, which aims to decrease accidental drug overdoses among servicemembers and veterans by implementing prescription drug take-back programs. The Drug Enforcement Administration can only authorize entities to collect and properly dispose of prescription drugs from ultimate users. Neither the Department of Defense (DoD) nor Department of Veterans Affairs (VA) is permitted to conduct prescription drug take-back programs at their pharmacies. This legislation would permit the Secretary of Defense and VA Secretary to implement prescription drug take-back programs for servicemembers, veterans, and families at DoD and VA pharmacies.

Read more:

Other State and Local News

State Unveils Prescription Drug Abuse Strategy
December 19, 2013

This article and video (2:26 minutes) discuss Oklahoma's plan of action to address prescription drug abuse. The campaign, "Take As Prescribed," has several initiatives, including increasing the number of drug disposal drop boxes statewide, expanding the sale of personal medication lock boxes, and enhancing the prescription monitoring program.

Read more:

Lifespan Adopts New Guidelines for Emergency-Room Painkillers
Providence Journal
December 17, 2013

The Providence-based Lifespan hospital group developed and adopted a set of prescribing guidelines that aim to address narcotic pain reliever abuse. The 11-point guidelines recommend doctors, physician assistants, and nurses write no more than 3-day prescriptions with no refills when prescribing narcotics, check computer records to ensure patients are not getting drugs from more than one doctor, avoid opioid injections for conditions such as migraines or dental pain, refer suspected addicts to treatment, and discuss the dangers of narcotic pain relievers with patients. These guidelines will help prescribers make appropriate decisions.

Read more:

Holidays: Lock Up the Medicine Chest
Indiana University, Indiana Prevention Resource Center
December 18, 2013

Public health experts at the Indiana University School of Public Health–Bloomington encourage families to lock up their prescription drugs and be mindful of the amount of alcohol they consume and make available. The article offers seven tips for staying safe this holiday season.

Read more:

Pills Couldn't Fix Ellen's Back
Cincinnati Enquirer
December 19, 2013

This article and video (3:04 minutes) discuss how Ellen Brinkerhoff used opioid pain relievers to deal with back pain for 10 years. When she was diagnosed with scoliosis, the doctor's plan was the same. Her pain began to improve after a year of physical therapy sessions, regular stretching, deep-tissue massages, belly dancing, and psychotherapy sessions. The Cincinnati Enquirer conducted intensive reporting throughout 2013 on the opioid and heroin crises, spending months examining medical treatment of pain, reviewing research, and interviewing dozens of medical professionals and patients. The paper discovered prescription opioids hurt more people than they help, and doctors are poorly prepared to treat chronic pain or identify those who will truly benefit from opioids. The Enquirer realized that Brinkerhoff's experience is common—it's difficult to receive treatment other than prescription pain relievers. Some approaches are not covered by health insurance and others require a lot of time from multiple physicians or great effort from patients.

Read more:

Prescription Drugs Pose Threats to Drivers
December 18, 2013

December is National Drugged and Drunk Driving Prevention Month and officials at Mercy Medical Center are reminding people not to drive under the influence of prescription drugs, which can become extremely dangerous when mixed with alcohol. Safe rides are available from Siouxland Taxi in Iowa.

Read more:

[Guest Column] Missouri Must Do More to Rein in Rx Abusers
St. Joseph News–Press
December 14, 2013

Jackie Spainhower, executive director of the St. Joseph Safety and Health Council, says strategies can be implemented by Missouri and community agencies to reduce prescription pain medication deaths. Such approaches include expansion of prescription drug monitoring programs; prescriber, employer, patient, and public education; pill mill regulation; responsible prescribing practices; safe disposal; and advocating for stronger laws.

Read more:

Maryland's Prescription Drug Monitoring Program Launches Today!
State of Maryland
December 19, 2013

Maryland's prescription drug monitoring program (PDMP) went live on December 19, 2013. The PDMP provides real-time information for healthcare providers, public health and law enforcement agencies, and other stakeholders throughout the state.

Read more:

Other Resources

Looking at Our Medicine Cabinets in a Different Light
National Education Association
December 19, 2013

The author encourages educators, parents, and caregivers to learn about prescription drug abuse and explain the dangers to young people. She recommends the National Education Association's fact sheet, "What Do You Know About Prescription Drug Abuse," which provides information on prescription drugs. Educators can also download two free resource guides designed to teach students about prescription drug abuse and misuse.

Read more:

National Drug Facts Week, January 27–February 2, 2014
National Institute on Drug Abuse
Accessed December 19, 2013

Community organizations are invited to register drug abuse awareness events for National Drug Facts Week (NDFW). This health observance week aims to counter myths about drug abuse, including nonmedical use of prescription drugs. NDFW combines community-based events with social media and online activities to provide teenagers with scientific and expert information. The National Institute on Drug Abuse provides planning information, while the AWARxE® Consumer Protection Program provides presentations, bookmarks, posters, flyers, brochures, and other resources on prescription drug abuse.

Read more:


Prescription Drug Monitoring Program (Condensed Version)
Chesapeake Regional Information System for our Patients
December 18, 2013

Maryland passed legislation to establish a prescription drug monitoring program (PDMP) in 2011. The state's goal was to assist healthcare providers and public health and safety authorities to reduce nonmedical use, abuse, and diversion of prescription drugs while preserving legitimate professional practice and patient access to optimal care. The program is overseen by the Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration. (Duration: 3:01 minutes)


The Prescription Drug Abuse Epidemic
December 16, 2013

Jane Velez–Mitchell discusses prescription drug abuse with Katherine Linton, director of MTV's True Life: I'm Addicted to Pills. Linton followed two drug users to film the documentary. Velez–Mitchell also talked with Dr. Drew about who to blame for this epidemic. (Duration: 5:41 minutes)


Angelo M. Valente, Ex. Dir. PDFNJ, Featured on Fox News' Geraldo at Large
The Partnership for a Drug-Free New Jersey
December 16, 2013

Angelo Valente, executive director of the Partnership for a Drug-Free New Jersey, and Angela Cicchino, a recovering heroin addict, were featured on Fox News' Geraldo at Large to discuss the heroin abuse epidemic. Valente explained heroin addiction usually begins with prescription pills. (Duration: 7:38 minutes)


Grant Announcement

Medical Toxicology Foundation Research Award: Prescription Drug Abuse Prevention
American College of Medical Toxicology
Deadline: February 14, 2014, 11:59 p.m. ET

Take-Back Events and Drop Boxes

Pa. Gov Touts Prescription Drug Drop-Off Boxes
Centre Daily Times
December 16, 2013

Governor Corbett Launches Statewide Healthy Pennsylvania Drug Take-Back Initiative
Digital Journal
December 16, 2013

Summit Police Department Announces Unused Prescription Drug Drop Off
Independent Press
December 13, 2013

Newark Police Taking Part in 'Medicine Drop'
Newark Patch
December 16, 2013

Cincinnati Enquirer to Purchase Prescription Medication Drop Boxes for Local Law Enforcement Agencies
Ohio Newspaper Association
December 17, 2013

Upcoming Conferences and Workshops

Lecture: Prescription Drug Use—The Dos and the Don'ts
January 29, 2014
Huntley, Illinois

SAMHSA's 10th Prevention Day
The Power of Prevention: Strengthening Behavioral Health and Public Health for the Next Decade
February 3, 2014
National Harbor, Maryland

24th National Leadership Forum: The Power of Movement
February 3–6, 2014
National Harbor, Maryland

Collaborative Perspectives on Addiction: Changing Addictive Behavior: Bench to Bedside and Back Again
February 28–March 1, 2014
Atlanta, Georgia

Pain Management Through a Wide Lens: Balancing Safety and Effectiveness
March 8, 2014
St. Louis, Missouri

11th Annual World Health Care Congress
April 7–9, 2014
National Harbor, Maryland

National Rx Drug Abuse Summit
April 22–24, 2014
Atlanta, Georgia

Prescription Drug Abuse and Diversion Crimes
June 10, 2014
Cottleville, Missouri
http://www.thepoliceacademy.org/2014.6.10. percent20Prescription.pdf
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full-text of journal articles listed in the Weekly Update.